Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 66

1.

The risk of cancer attributable to diagnostic medical radiation: Estimation for France in 2015.

Marant-Micallef C, Shield KD, Vignat J, Cléro E, Kesminiene A, Hill C, Rogel A, Vacquier B, Bray F, Laurier D, Soerjomataram I.

Int J Cancer. 2019 Jun 15;144(12):2954-2963. doi: 10.1002/ijc.32048. Epub 2019 Jan 15.

PMID:
30537057
2.

Antibodies to Costimulatory Receptor 4-1BB Enhance Anti-tumor Immunity via T Regulatory Cell Depletion and Promotion of CD8 T Cell Effector Function.

Buchan SL, Dou L, Remer M, Booth SG, Dunn SN, Lai C, Semmrich M, Teige I, Mårtensson L, Penfold CA, Chan HTC, Willoughby JE, Mockridge CI, Dahal LN, Cleary KLS, James S, Rogel A, Kannisto P, Jernetz M, Williams EL, Healy E, Verbeek JS, Johnson PWM, Frendéus B, Cragg MS, Glennie MJ, Gray JC, Al-Shamkhani A, Beers SA.

Immunity. 2018 Nov 20;49(5):958-970.e7. doi: 10.1016/j.immuni.2018.09.014. Epub 2018 Nov 13.

PMID:
30446386
3.

Cancers related to lifestyle and environmental factors in France in 2015.

Soerjomataram I, Shield K, Marant-Micallef C, Vignat J, Hill C, Rogel A, Menvielle G, Dossus L, Ormsby JN, Rehm J, Rushton L, Vineis P, Parkin M, Bray F.

Eur J Cancer. 2018 Dec;105:103-113. doi: 10.1016/j.ejca.2018.09.009. Epub 2018 Nov 14.

PMID:
30445359
4.

Breast cancer screening programme participation and socioeconomic deprivation in France.

Deborde T, Chatignoux E, Quintin C, Beltzer N, Hamers FF, Rogel A.

Prev Med. 2018 Oct;115:53-60. doi: 10.1016/j.ypmed.2018.08.006. Epub 2018 Aug 9.

PMID:
30099047
5.

Implementation and organization of cancer screening in France.

Hamers FF, Assogba FAG, Rogel A.

Int J Cancer. 2018 Dec 15;143(12):3281. doi: 10.1002/ijc.31630. Epub 2018 Oct 16. No abstract available.

PMID:
29943827
6.

PD-1 Blockade and CD27 Stimulation Activate Distinct Transcriptional Programs That Synergize for CD8+ T-Cell-Driven Antitumor Immunity.

Buchan SL, Fallatah M, Thirdborough SM, Taraban VY, Rogel A, Thomas LJ, Penfold CA, He LZ, Curran MA, Keler T, Al-Shamkhani A.

Clin Cancer Res. 2018 May 15;24(10):2383-2394. doi: 10.1158/1078-0432.CCR-17-3057. Epub 2018 Mar 7.

7.

The impact of historical breastfeeding practices on the incidence of cancer in France in 2015.

Shield KD, Dossus L, Fournier A, Marant Micallef C, Rinaldi S, Rogel A, Heard I, Pilleron S, Bray F, Soerjomataram I.

Cancer Causes Control. 2018 Mar;29(3):325-332. doi: 10.1007/s10552-018-1015-2. Epub 2018 Feb 20.

PMID:
29464426
8.

The immunobiology of CD27 and OX40 and their potential as targets for cancer immunotherapy.

Buchan SL, Rogel A, Al-Shamkhani A.

Blood. 2018 Jan 4;131(1):39-48. doi: 10.1182/blood-2017-07-741025. Epub 2017 Nov 8. Review.

9.

Akt signaling is critical for memory CD8+ T-cell development and tumor immune surveillance.

Rogel A, Willoughby JE, Buchan SL, Leonard HJ, Thirdborough SM, Al-Shamkhani A.

Proc Natl Acad Sci U S A. 2017 Feb 14;114(7):E1178-E1187. doi: 10.1073/pnas.1611299114. Epub 2017 Jan 30.

10.

Incidence of major smoking-related cancers: trends among adults aged 20-44 in France from 1982 to 2012.

Gilhodes J, Belot A, Bouvier AM, Remontet L, Delafosse P, Ligier K, Rogel A.

Cancer Epidemiol. 2015 Oct;39(5):707-13. doi: 10.1016/j.canep.2015.07.001. Epub 2015 Jul 22.

11.

Transient Adverse Side Effects During Neurofeedback Training: A Randomized, Sham-Controlled, Double Blind Study.

Rogel A, Guez J, Getter N, Keha E, Cohen T, Amor T, Todder D.

Appl Psychophysiol Biofeedback. 2015 Sep;40(3):209-18. doi: 10.1007/s10484-015-9289-6.

PMID:
26008757
12.

OX40- and CD27-mediated costimulation synergizes with anti-PD-L1 blockade by forcing exhausted CD8+ T cells to exit quiescence.

Buchan S, Manzo T, Flutter B, Rogel A, Edwards N, Zhang L, Sivakumaran S, Ghorashian S, Carpenter B, Bennett C, Freeman GJ, Sykes M, Croft M, Al-Shamkhani A, Chakraverty R.

J Immunol. 2015 Jan 1;194(1):125-133. doi: 10.4049/jimmunol.1401644. Epub 2014 Nov 17.

13.

Influence of electroencephalography neurofeedback training on episodic memory: a randomized, sham-controlled, double-blind study.

Guez J, Rogel A, Getter N, Keha E, Cohen T, Amor T, Gordon S, Meiran N, Todder D.

Memory. 2015;23(5):683-94. doi: 10.1080/09658211.2014.921713. Epub 2014 Jun 2.

PMID:
24885307
14.

Differential impact of CD27 and 4-1BB costimulation on effector and memory CD8 T cell generation following peptide immunization.

Willoughby JE, Kerr JP, Rogel A, Taraban VY, Buchan SL, Johnson PW, Al-Shamkhani A.

J Immunol. 2014 Jul 1;193(1):244-51. doi: 10.4049/jimmunol.1301217. Epub 2014 May 23.

15.

National cancer incidence is estimated using the incidence/mortality ratio in countries with local incidence data: is this estimation correct?

Uhry Z, Belot A, Colonna M, Bossard N, Rogel A, Iwaz J, Mitton N, Grosclaude P, Remontet L.

Cancer Epidemiol. 2013 Jun;37(3):270-7. doi: 10.1016/j.canep.2012.12.007. Epub 2013 Jan 9.

PMID:
23312453
16.

MELOE-1 antigen contains multiple HLA class II T cell epitopes recognized by Th1 CD4+ T cells from melanoma patients.

Bobinet M, Vignard V, Rogel A, Khammari A, Dreno B, Lang F, Labarriere N.

PLoS One. 2012;7(12):e51716. doi: 10.1371/journal.pone.0051716. Epub 2012 Dec 20.

17.

Cancer incidence estimation at a district level without a national registry: a validation study for 24 cancer sites using French health insurance and registry data.

Uhry Z, Remontet L, Colonna M, Belot A, Grosclaude P, Mitton N, Delacour-Billon S, Gentil J, Boussac-Zarebska M, Bossard N, Danzon A, Altana M, Frete F, Weill A, Rogel A.

Cancer Epidemiol. 2013 Apr;37(2):99-114. doi: 10.1016/j.canep.2012.10.010. Epub 2012 Nov 30.

PMID:
23200731
18.

CD137 on inflamed lymphatic endothelial cells enhances CCL21-guided migration of dendritic cells.

Teijeira Á, Palazón A, Garasa S, Marré D, Aubá C, Rogel A, Murillo O, Martínez-Forero I, Lang F, Melero I, Rouzaut A.

FASEB J. 2012 Aug;26(8):3380-92. doi: 10.1096/fj.11-201061. Epub 2012 May 16.

PMID:
22593548
19.

A 5-aza-2'-deoxycytidine/valproate combination induces cytotoxic T-cell response against mesothelioma.

Leclercq S, Gueugnon F, Boutin B, Guillot F, Blanquart C, Rogel A, Padieu M, Pouliquen D, Fonteneau JF, Grégoire M.

Eur Respir J. 2011 Nov;38(5):1105-16. doi: 10.1183/09031936.00081310. Epub 2011 May 3.

20.

Modelling the effect of breast cancer screening on related mortality using French data.

Uhry Z, Hédelin G, Colonna M, Asselain B, Arveux P, Exbrayat C, Guldenfelds C, Soler-Michel P, Molinié F, Trétarre B, Rogel A, Courtial I, Danzon A, Guizard AV, Ancelle-Park R, Eilstein D, Duffy S.

Cancer Epidemiol. 2011 Jun;35(3):235-42. doi: 10.1016/j.canep.2010.10.009. Epub 2010 Dec 14.

PMID:
21159568
21.

Reliability of recording uterine cancer in death certification in France and age-specific proportions of deaths from cervix and corpus uteri.

Rogel A, Belot A, Suzan F, Bossard N, Boussac M, Arveux P, Buémi A, Colonna M, Danzon A, Ganry O, Guizard AV, Grosclaude P, Velten M, Jougla E, Iwaz J, Estève J, Chérié-Challine L, Remontet L.

Cancer Epidemiol. 2011 Jun;35(3):243-9. doi: 10.1016/j.canep.2010.10.008. Epub 2010 Nov 23.

PMID:
21106450
22.

A long peptide from MELOE-1 contains multiple HLA class II T cell epitopes in addition to the HLA-A*0201 epitope: an attractive candidate for melanoma vaccination.

Rogel A, Vignard V, Bobinet M, Labarriere N, Lang F.

Cancer Immunol Immunother. 2011 Mar;60(3):327-37. doi: 10.1007/s00262-010-0938-6. Epub 2010 Nov 16.

PMID:
21080167
23.

Multi-state Markov models in cancer screening evaluation: a brief review and case study.

Uhry Z, Hédelin G, Colonna M, Asselain B, Arveux P, Rogel A, Exbrayat C, Guldenfels C, Courtial I, Soler-Michel P, Molinié F, Eilstein D, Duffy SW.

Stat Methods Med Res. 2010 Oct;19(5):463-86. doi: 10.1177/0962280209359848. Epub 2010 Mar 15. Review.

PMID:
20231370
24.

Relationship between occupational exposure to ionizing radiation and mortality at the French electricity company, period 1961-2003.

Laurent O, Metz-Flamant C, Rogel A, Hubert D, Riedel A, Garcier Y, Laurier D.

Int Arch Occup Environ Health. 2010 Dec;83(8):935-44. doi: 10.1007/s00420-010-0509-3. Epub 2010 Feb 11.

PMID:
20148259
25.

Mortality among workers monitored for radiation exposure at the French nuclear fuel company.

Metz-Flamant C, Rogel A, Caër S, Samson E, Laurier D, Acker A, Tirmarche M.

Arch Environ Occup Health. 2009 Winter;64(4):242-50. doi: 10.1080/19338240903348246.

PMID:
20007120
26.

[Mortality in nuclear workers of the French electricity company: period 1968-2003].

Rogel A, Joly K, Metz-Flamant C, Laurent O, Tirmarche M, Hubert D, Garcier Y, Laurier D.

Rev Epidemiol Sante Publique. 2009 Aug;57(4):257-65. doi: 10.1016/j.respe.2009.03.004. Epub 2009 Jun 21. French.

PMID:
19540685
27.

Ionizing radiation and risk of chronic lymphocytic leukemia in the 15-country study of nuclear industry workers.

Vrijheid M, Cardis E, Ashmore P, Auvinen A, Gilbert E, Habib RR, Malker H, Muirhead CR, Richardson DB, Rogel A, Schubauer-Berigan M, Tardy H, Telle-Lamberton M; 15-Country Study Group.

Radiat Res. 2008 Nov;170(5):661-5. doi: 10.1667/RR1443.1.

28.

Radon-associated lung cancer risk among French uranium miners: modifying factors of the exposure-risk relationship.

Vacquier B, Rogel A, Leuraud K, Caer S, Acker A, Laurier D.

Radiat Environ Biophys. 2009 Feb;48(1):1-9. doi: 10.1007/s00411-008-0196-6. Epub 2008 Oct 24.

PMID:
18949479
29.

Dose conversion of radon exposure according to new epidemiological findings.

Tomasek L, Rogel A, Laurier D, Tirmarche M.

Radiat Prot Dosimetry. 2008;130(1):98-100. doi: 10.1093/rpd/ncn117. Epub 2008 Apr 8.

PMID:
18397930
30.

Lung cancer in French and Czech uranium miners: Radon-associated risk at low exposure rates and modifying effects of time since exposure and age at exposure.

Tomasek L, Rogel A, Tirmarche M, Mitton N, Laurier D.

Radiat Res. 2008 Feb;169(2):125-37. doi: 10.1667/RR0848.1.

PMID:
18220460
31.

Mortality risk in the French cohort of uranium miners: extended follow-up 1946-1999.

Vacquier B, Caer S, Rogel A, Feurprier M, Tirmarche M, Luccioni C, Quesne B, Acker A, Laurier D.

Occup Environ Med. 2008 Sep;65(9):597-604. Epub 2007 Dec 20.

PMID:
18096654
32.

Cancer mortality risk among biology research workers in France: first results of two retrospective cohorts studies.

Guseva Canu I, Rogel A, Samson E, Benhamou S, Laplanche A, Tirmarche M.

Int Arch Occup Environ Health. 2008 May;81(6):777-85. Epub 2007 Oct 10.

PMID:
17929049
33.

Mortality from diseases other than cancer following low doses of ionizing radiation: results from the 15-Country Study of nuclear industry workers.

Vrijheid M, Cardis E, Ashmore P, Auvinen A, Bae JM, Engels H, Gilbert E, Gulis G, Habib R, Howe G, Kurtinaitis J, Malker H, Muirhead C, Richardson D, Rodriguez-Artalejo F, Rogel A, Schubauer-Berigan M, Tardy H, Telle-Lamberton M, Usel M, Veress K.

Int J Epidemiol. 2007 Oct;36(5):1126-35. Epub 2007 Jul 31.

PMID:
17666424
34.

The 15-Country Collaborative Study of Cancer Risk Among Radiation Workers in the Nuclear Industry: design, epidemiological methods and descriptive results.

Vrijheid M, Cardis E, Blettner M, Gilbert E, Hakama M, Hill C, Howe G, Kaldor J, Muirhead CR, Schubauer-Berigan M, Yoshimura T, Ahn YO, Ashmore P, Auvinen A, Bae JM, Engels H, Gulis G, Habib RR, Hosoda Y, Kurtinaitis J, Malker H, Moser M, Rodriguez-Artalejo F, Rogel A, Tardy H, Telle-Lamberton M, Turai I, Usel M, Veress K.

Radiat Res. 2007 Apr;167(4):361-79.

PMID:
17388694
35.

The 15-Country Collaborative Study of Cancer Risk among Radiation Workers in the Nuclear Industry: estimates of radiation-related cancer risks.

Cardis E, Vrijheid M, Blettner M, Gilbert E, Hakama M, Hill C, Howe G, Kaldor J, Muirhead CR, Schubauer-Berigan M, Yoshimura T, Bermann F, Cowper G, Fix J, Hacker C, Heinmiller B, Marshall M, Thierry-Chef I, Utterback D, Ahn YO, Amoros E, Ashmore P, Auvinen A, Bae JM, Bernar J, Biau A, Combalot E, Deboodt P, Diez Sacristan A, Eklöf M, Engels H, Engholm G, Gulis G, Habib RR, Holan K, Hyvonen H, Kerekes A, Kurtinaitis J, Malker H, Martuzzi M, Mastauskas A, Monnet A, Moser M, Pearce MS, Richardson DB, Rodriguez-Artalejo F, Rogel A, Tardy H, Telle-Lamberton M, Turai I, Usel M, Veress K.

Radiat Res. 2007 Apr;167(4):396-416.

PMID:
17388693
36.

The neuroprotective adenosine-activated signal transduction pathway involves activation of phospholipase C.

Rogel A, Bromberg Y, Sperling O, Zoref-Shani E.

Nucleosides Nucleotides Nucleic Acids. 2006;25(9-11):1283-6.

PMID:
17065107
37.

Lung cancer attributable to indoor radon exposure in france: impact of the risk models and uncertainty analysis.

Catelinois O, Rogel A, Laurier D, Billon S, Hemon D, Verger P, Tirmarche M.

Environ Health Perspect. 2006 Sep;114(9):1361-6.

39.

Risk of cancer after low doses of ionising radiation: retrospective cohort study in 15 countries.

Cardis E, Vrijheid M, Blettner M, Gilbert E, Hakama M, Hill C, Howe G, Kaldor J, Muirhead CR, Schubauer-Berigan M, Yoshimura T, Bermann F, Cowper G, Fix J, Hacker C, Heinmiller B, Marshall M, Thierry-Chef I, Utterback D, Ahn YO, Amoros E, Ashmore P, Auvinen A, Bae JM, Solano JB, Biau A, Combalot E, Deboodt P, Diez Sacristan A, Eklof M, Engels H, Engholm G, Gulis G, Habib R, Holan K, Hyvonen H, Kerekes A, Kurtinaitis J, Malker H, Martuzzi M, Mastauskas A, Monnet A, Moser M, Pearce MS, Richardson DB, Rodriguez-Artalejo F, Rogel A, Tardy H, Telle-Lamberton M, Turai I, Usel M, Veress K.

BMJ. 2005 Jul 9;331(7508):77. Epub 2005 Jun 29.

40.

Uncertainty and sensitivity analysis in assessment of the thyroid cancer risk related to Chernobyl fallout in Eastern France.

Catelinois O, Laurier D, Verger P, Rogel A, Colonna M, Ignasiak M, Hémon D, Tirmarche M.

Risk Anal. 2005 Apr;25(2):243-52.

PMID:
15876201
41.

Studies of radon-exposed miner cohorts using a biologically based model: comparison of current Czech and French data with historic data from China and Colorado.

Heidenreich WF, Tomásek L, Rogel A, Laurier D, Tirmarche M.

Radiat Environ Biophys. 2004 Dec;43(4):247-56. Epub 2004 Nov 30.

PMID:
15645313
42.
43.

Mortality of workers exposed to ionizing radiation at the French National Electricity Company.

Rogel A, Carré N, Amoros E, Bonnet-Belfais M, Goldberg M, Imbernon E, Calvez T, Hill C.

Am J Ind Med. 2005 Jan;47(1):72-82.

PMID:
15597358
44.

Projecting the time trend of thyroid cancers: its impact on assessment of radiation-induced cancer risks.

Catelinois O, Verger P, Colonna M, Rogel A, Hemon D, Tirmarche M.

Health Phys. 2004 Dec;87(6):606-14.

PMID:
15545767
45.

Inhibition of foot-and-mouth disease virus replication by small interfering RNA.

Kahana R, Kuznetzova L, Rogel A, Shemesh M, Hai D, Yadin H, Stram Y.

J Gen Virol. 2004 Nov;85(Pt 11):3213-7.

PMID:
15483234
46.

Radon-induced lung cancer in French and Czech miner cohorts described with a two-mutation cancer model.

Brugmans MJ, Rispens SM, Bijwaard H, Laurier D, Rogel A, Tomásek L, Tirmarche M.

Radiat Environ Biophys. 2004 Sep;43(3):153-63. Epub 2004 Aug 17.

PMID:
15316819
47.

Discussion on radon and leukemia risk in underground miners: are working level months the most appropriate exposure parameter?

Laurier D, Rogel A, Valenty M, Tirmarche M.

Health Phys. 2004 Apr;86(4):427-8. No abstract available.

PMID:
15057067
48.

Detection and quantitation of akabane and aino viruses by multiplex real-time reverse-transcriptase PCR.

Stram Y, Kuznetzova L, Guini M, Rogel A, Meirom R, Chai D, Yadin H, Brenner J.

J Virol Methods. 2004 Mar 15;116(2):147-54.

PMID:
14738981
49.

Seasonal correction factors for estimating radon exposure in dwellings in France.

Baysson H, Billon S, Laurier D, Rogel A, Tirmarche M.

Radiat Prot Dosimetry. 2003;104(3):245-52.

PMID:
14565731
50.

Vaccination with E. coli recombinant empty viral particles of infectious bursal disease virus (IBDV) confer protection.

Rogel A, Benvenisti L, Sela I, Edelbaum O, Tanne E, Shachar Y, Zanberg Y, Gontmakher T, Khayat E, Stram Y.

Virus Genes. 2003 Oct;27(2):169-75.

PMID:
14501195

Supplemental Content

Support Center